Exane Derivatives’s New Relic, Inc. NEWR Stock Holding History

Exane Derivatives’s Portfolio NEWR Stock Details NEWR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$1.15K	Sell	23 -2,206	-99%	-$122K	﹤0.01%	494
2022 Q1	$149K	Sell	2,229 -254	-10%	-$20.8K	0.04%	404
2021 Q4	$273K	Buy	2,483 +2,482	+248,200%	+$239K	0.07%	279
2021 Q3	$72	Hold	1	–	–	﹤0.01%	1028
2021 Q2	$65	Hold	1	–	–	﹤0.01%	1030
2021 Q1	$61	Hold	1	–	–	﹤0.01%	865
2020 Q4	$65	Hold	1	–	–	﹤0.01%	806
2020 Q3	$56	Hold	1	–	–	﹤0.01%	737
2020 Q2	$69	Hold	1	–	–	﹤0.01%	671
2020 Q1	$46	Hold	1	–	–	﹤0.01%	682
2019 Q4	$73	Hold	1	–	–	﹤0.01%	661
2019 Q3	$61	Hold	1	–	–	﹤0.01%	640
2019 Q2	$86	Hold	1	–	–	﹤0.01%	643
2019 Q1	$99	Hold	1	–	–	﹤0.01%	583
2018 Q4	$81	Hold	1	–	–	﹤0.01%	645
2018 Q3	$95	Hold	1	–	–	﹤0.01%	624
2018 Q2	$100	Sell	1 -30	-97%	-$2.67K	﹤0.01%	615
2018 Q1	$2.26K	Sell	31 -5,161	-99%	-$346K	﹤0.01%	443
2017 Q4	$300K	Sell	5,192 -10,853	-68%	-$591K	0.05%	204
2017 Q3	$799K	Buy	+16,045	New	+$758K	0.15%	95

Other funds holding NEWR

Eminence Capital New York $4.36B AUM 3.1% 1-Year Est. Return

HCM

HMI Capital Management San Francisco, California $712M AUM 26.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Jana Partners New York $1.34B AUM 4.95% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

CAM

Contour Asset Management New York $4.22B AUM 26.55% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return

Engaged Capital Newport Beach, California $327M AUM 22.96% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Exane Derivatives's NEWR Position: Q2 2022 in Review

Exane Derivatives reduced its New Relic, Inc. (NEWR) stake by 99% in Q2 2022, selling an estimated $122K and leaving 23 shares worth $1.15K. The position accounts for ﹤0.01% of the portfolio, ranked #494.

Exane Derivatives first reported a position in NEWR in Q3 2017 and has held it in 20 quarters since. The position peaked at $799K in Q3 2017. 233 funds tracked by Wall St. Rank hold NEWR as of Q2 2022.

Exane Derivatives held 23 shares of New Relic, Inc. worth $1.15K as of Q2 2022.
Exane Derivatives sold 2,206 New Relic, Inc. shares in Q2 2022, an estimated $122K.
New Relic, Inc. made up ﹤0.01% of Exane Derivatives's portfolio in Q2 2022, its #494 holding.
Exane Derivatives first reported a position in New Relic, Inc. in Q3 2017 and has held it in 20 quarters since.
Exane Derivatives's New Relic, Inc. position peaked at $799K in Q3 2017.
233 funds tracked by Wall St. Rank held New Relic, Inc. as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.